↓ Skip to main content

The advent of oncolytic virotherapy in oncology: The Rigvir® story

Overview of attention for article published in European Journal of Pharmacology, September 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (78th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
6 X users
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
111 Dimensions

Readers on

mendeley
132 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
The advent of oncolytic virotherapy in oncology: The Rigvir® story
Published in
European Journal of Pharmacology, September 2018
DOI 10.1016/j.ejphar.2018.08.042
Pubmed ID
Authors

Pēteris Alberts, Andra Tilgase, Agnija Rasa, Katrīna Bandere, Dite Venskus

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 132 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 14%
Student > Ph. D. Student 14 11%
Researcher 14 11%
Student > Master 13 10%
Student > Doctoral Student 9 7%
Other 13 10%
Unknown 50 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 20 15%
Medicine and Dentistry 16 12%
Immunology and Microbiology 13 10%
Agricultural and Biological Sciences 12 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 4%
Other 9 7%
Unknown 57 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2021.
All research outputs
#4,244,876
of 25,837,817 outputs
Outputs from European Journal of Pharmacology
#827
of 8,793 outputs
Outputs of similar age
#75,444
of 348,640 outputs
Outputs of similar age from European Journal of Pharmacology
#7
of 75 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,793 research outputs from this source. They receive a mean Attention Score of 4.4. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 348,640 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 78% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.